相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Perinatal Transmission of 2019 Coronavirus Disease-Associated Severe Acute Respiratory Syndrome Coronavirus 2: Should We Worry?
Cuifang Fan et al.
CLINICAL INFECTIOUS DISEASES (2021)
What are the risks of COVID-19 infection in pregnant women?
Jie Qiao
LANCET (2020)
Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records
Huijun Chen et al.
LANCET (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Validation of algorithms to identify adverse perinatal outcomes in the Medicaid Analytic Extract database
Mengdong He et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2020)
Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets
Su-Jin Park et al.
MBIO (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China
Lian Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Quantification of selection bias in studies of risk factors for birth defects among livebirths
Dominique Heinke et al.
PAEDIATRIC AND PERINATAL EPIDEMIOLOGY (2020)
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy A Cohort Study
Julia del Amo et al.
ANNALS OF INTERNAL MEDICINE (2020)
Antiretrovirals and Risk of COVID-19 Diagnosis and Hospitalization in HIV-Positive Persons
Julia del Amo et al.
EPIDEMIOLOGY (2020)
Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-June 7, 2020
Sascha Ellington et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19
Minchen Chien et al.
JOURNAL OF PROTEOME RESEARCH (2020)
Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study
Abdo A. Elfiky
LIFE SCIENCES (2020)
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19 A Randomized Clinical Trial
Christoph D. Spinner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-October 3, 2020
Laura D. Zambrano et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals
Noelle Breslin et al.
AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM (2020)
Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia
Huaping Zhu et al.
TRANSLATIONAL PEDIATRICS (2020)
Maternal and Infant Bone Mineral Density 1 Year After Delivery in a Randomized, Controlled Trial of Maternal Tenofovir Disoproxil Fumarate to Prevent Mother-to-child Transmission of Hepatitis B Virus
Nicolas Salvadori et al.
CLINICAL INFECTIOUS DISEASES (2019)
Birth Outcomes for Pregnant Women with HIV Using Tenofovir-Emtricitabine
Kathryn Rough et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
A Propensity-score-based Fine Stratification Approach for Confounding Adjustment When Exposure Is Infrequent
Rishi J. Desai et al.
EPIDEMIOLOGY (2017)
Zidovudine use in pregnancy and congenital malformations
Kathryn Rough et al.
AIDS (2017)
Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis
Robert S. Brown et al.
HEPATOLOGY (2016)
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
M. G. Fowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The Obstetric Comorbidity Index predicts severe maternal morbidity
B. T. Bateman et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2015)
Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy
George K. Siberry et al.
CLINICAL INFECTIOUS DISEASES (2015)
Congenital Anomalies and In Utero Antiretroviral Exposure in Human Immunodeficiency Virus-Exposed Uninfected Infants
Paige L. Williams et al.
JAMA PEDIATRICS (2015)
Trends in Antiretroviral Drug Use During Pregnancy Among HIV-Infected Women on Medicaid: 2000-2007
Kelesitse Phiri et al.
AIDS PATIENT CARE AND STDS (2014)
First Trimester Exposure to Antiretroviral Therapy and Risk of Birth Defects
Kelesitse Phiri et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2014)
Validity of maternal and infant outcomes within nationwide Medicaid data
Kristin Palmsten et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2014)
Association between Prenatal Exposure to Antiretroviral Therapy and Birth Defects: An Analysis of the French Perinatal Cohort Study (ANRS CO1/CO11)
Jeanne Sibiude et al.
PLOS MEDICINE (2014)
Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011
M. Floridia et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2013)
Harnessing the Medicaid Analytic eXtract (MAX) to Evaluate Medications in Pregnancy: Design Considerations
Kristin Palmsten et al.
PLOS ONE (2013)
Prevalence of Congenital Anomalies in Infants With In Utero Exposure to Antiretrovirals
Katherine M. Knapp et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Birth Defects Among Children Born to Human Immunodeficiency Virus-Infected Women Pediatric AIDS Clinical Trials Protocols 219 and 219C
Susan B. Brogly et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2010)
Positive predictive value of computerized records for major congenital malformations
William O. Cooper et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
分享论文
